The concomitant presence of diabetes mellitus and arterial hypertension significantly impairs myocardial function through a direct negative effect on cardiac myocytes, coronary microvessels and precipitation of atherosclerosis in major coronary arteries. The purpose of the present study was to establish to what extent non-insulin dependent diabetes mellitus (NIDDM) modified silent myocardial ischaemia (SMI) in patients with essential hypertension and without documented coronary artery disease (CAD).
Introduction
Essential arterial hypertension and non-insulin dependent diabetes mellitus (NIDDM) are frequent diseases in the world. They are also well known coronary risk factors, and their concomitant presence increases considerably the risk of coronary artery disease (CAD). Insulin resistance, hyperinsulinaemia, impaired glucose tolerance or overt NIDDM associated with obesity, arterial hypertension, dyslipidaemia, hyperuricaemia, altered coagulation and fibrinolysis, and with CAD are the components of the syndrome X defined by Reaven. From the prognostic and therapeutic point of view it is important to establish the role of diabetes mellitus and arterial hypertension in the development of myocardial Correspondence: Wojciech Lubaszewski, I Cardiac Department, Jagiellonian University School of Medicine, Kopernika 17 Str., 31-501 Krakó w, Poland Received 16 January 1998; revised 15 September and 21 December 1998; accepted 2 February 1999 SMI was more frequent in group I than in group II (29.3% vs 12.5%, P Ͻ 0.05). In group I the total duration of SMI was longer (37.3 vs 2.8 min, P Ͻ 0.001) and the total number of silent episodes was larger (15.5 vs 2.6, P Ͻ 0.001). No inter-group differences were seen in conventional and automatic blood pressure and heart rate measurements. Both groups did not differ significantly in left ventricular mass index (LVMI) or the proportion of patients with left ventricular hypertrophy (LVH) (75.6% vs 60%). Lipid profile in both groups indicated an increased risk of CAD, but without significant differences.
In conclusion, in patients with essential arterial hypertension and diabetes mellitus, the incidence and severity of SMI were clearly higher than in hypertensives with normal carbohydrate metabolism. Employment of modern diagnostic techniques in hypertensives permits identification of those at greater risk, which may have further clinical implications.
ischaemia. CAD occurs in a number of clinical forms, including silent or asymptomatic myocardial ischaemia. Silent myocardial ischaemia (SMI) is diagnosed on the basis of transient ST segment depressions, myocardial perfusion defects or reversible segmental wall motion disorders. Although SMI was identified some time ago, the phenomenon attracts growing attention due to the availability of refined techniques for its diagnosis.
The aim of the study was to establish to what extent NIDDM modified the development of silent myocardial ischaemia in patients with essential hypertension and without signs of CAD.
Patients and methods
Patients with mild to moderate essential arterial hypertension were enrolled after having given informed consent to the study, which had been approved by the Ethics Committee of the Jagiellonian University in Krakó w, Poland. Secondary hypertension was excluded in all patients. Those with docu-mented CAD, chest pain, nitrate therapy, hormonal contraceptive or hormone replacement therapy (women) and those with tachycardia at rest or orthostatic hypotension were also excluded. Out of 140 initially recruited patients, 27 with the ECG preventing from a reliable analysis of the ST-T segment in the planned 24 h ECG monitoring (the signs of left ventricular strain and hypertrophy, atrioventricular and intraventricular conduction disorders, preexcitation, atrial flutter or fibrillation) were excluded from further studies. The reason for exclusion in nine patients was the impossibility to reduce hypotensive therapy 2 weeks prior to the study. Technically unacceptable 24 h ECG recordings were found in 14 patients, and hyperventilatory and postural ST segment changes were detected in nine patients.
Thus, 81 patients were selected for final analysis: group I-41 hypertensives with NIDDM (treated with diet and oral hypoglycaemic agents); and group II-40 hypertensives without NIDDM (confirmed by oral glucose tolerance test). Table 1 provides basic characteristics of the study population. Both groups were comparable with respect to gender, age, smoking habits, duration of hypertension, whereas body mass index (BMI) was higher in group I, ie hypertensives with NIDDM.
In all patients usual combined antihypertensive therapy was discontinued for 2 weeks prior to the study and replaced with captopril in a dose of 12.5 mg t.i.d.
Arterial blood pressure (BP) was measured twice with a mercury sphygmomanometer at three consecutive out-patient visits in standard conditions. An average of all measurements was considered for statistical analysis.
Arterial BP and heart rate were monitored for 24 h (SpaceLabs 90207: SpaceLabs Inc, WA, USA) with recordings at 30 min intervals. Measurements of pulse amplitude Ͻ20 mm Hg or Ͼ150 mm Hg, systolic BP (SBP) Ͼ260 mm Hg or Ͻ70 mm Hg and diastolic BP (DBP) Ͼ150 mm Hg or Ͻ40 mm Hg were excluded from analysis. The parameters were assessed for the entire 24 h and separately for the daytime (06.00-22.00) and night-time (22.00-06.00). All patients underwent continuous ECG recording (Mediarc-Premier IV Holter Monitoring System, DRG-International, Mountainside, NJ, USA). Analysis was carried out with the original DRG software and manual verification of the ECG strip. The patients were familiarised with the equipment and after its connection they made postural and respiratory tests to verify the quality and reliability of further recordings. The patients then returned to their normal daily life activities. All cigarette smokers declared not to smoke throughout the entire 24-h recording period.
On the basis of 24-h ECG recording maximum, minimum and mean heart rate (HR max , HR min and HR mean ), respectively was calculated, type and frequency of cardiac arrhythmias were identified, and presence of silent myocardial ischaemia was recorded. Horizontal or down-sloping ST segment depression у1 mm at 70 ms from the J-point lasting for at least 1 min without the associated chest pain or its equivalents was defined as an asymptomatic (SMI) episode. [1] [2] [3] Analysis of SMI included: total duration of SMI during the entire 24 h, total number of SMI episodes during the entire 24 h, number of SMI episodes lasting 1 min, number of SMI episodes lasting 2-4 min, number of SMI episodes lasting у5 min, duration of the longest SMI episode in the entire recording period, maximum ST segment depression during SMI.
M-mode and 2-D guided echocardiograms (Hewlett Packard AC 77020, Andover, MA, USA) were obtained with the 2.5 MHz/3.5 MHz transducer in standard conditions by two independent observers according to the recommendations of the American Society of Echocardiography (ASE). 4 At least three measurements were averaged to calculate left ventricular dimension at diastole (LVDd), left ventricular dimension at systole (LVDs), interventricular septal thickness at diastole (IVSDd), interventricular septal thickness at systole (IVSDs), posterior wall thickness at diastole (PWTDd), posterior wall thickness at systole (PWTDs). Left ventricular mass (LVM) was calculated according to Devereux modified by ASE. Left ventricular mass index (LVMI) was calculated from left ventricular mass and body surface area. Left ventricular hypertrophy was diagnosed when LVMI was Ͼ134 g/m 2 in men, and Ͼ109 g/m 2 in women. [5] [6] [7] [8] In all patients blood was sampled to determine basic biochemical indices (using an automatic analyser SMA 12/60, Techicon Instruments Corporation Tarrytown, NY, USA) and lipid profile (using a biochemical analyser: Technicon RA-1000).
Statistical analysis
Paired Student's t-test was performed to test for statistical significance. Chi-square test and exact Fisher's test were performed to test for independence of discrete (coded) variables. Analysis of variance with additional verification of differences between means 
Results

Blood pressure measurements
Conventional mean SBP and DBP and heart rate at rest did not differ significantly between the groups (Table 2) . Mean SBP, DBP and heart rate in 24 h ambulatory BP monitoring (ABPM) were comparable in both groups (Table 3) . All recorded episodes of ST segment depression were silent. In group I SMI was significantly more frequent (in 12 (29.3%) of patients) than in group II (5 (12.4%) patients) (P Ͻ 0.05). Table 4 summarises the severity of SMI in both groups. Table 5 shows the cumulative daily distribution of SMI episodes in both groups.
Continuous ECG monitoring
The incidence of ventricular extrasystoles in patients with SMI has been analysed in a similar way. The time intervals did not differ significantly in the number of ventricular extrasystoles.
Echocardiography
Echocardiography did not reveal significant differences in LVM (group I: 281.9 ± 66.7 g vs group II: 258.7 ± 57. ) between groups. No significant differences were seen in the number of patients with left ventricular hypertrophy (group I: 31 (75.6%) vs group II: 24 (60%)).
Biochemical measurements
Mean lipid values did not differ significantly between the groups. In both groups they were slightly elevated and corresponded to mild hyperli- Table 5 Cumulative daily distribution of SMI episodes in both groups.
Time intervals (hours)
Number of SMI episodes P Ͻ 0.05 pidaemia. Glycaemia in diabetics was significantly higher than in non-diabetics (Table 6 ).
Discussion
In both groups BMI exceeded the limits of normal, especially in diabetic hypertensives. It is in accordance with a well known observation that essential arterial hypertension develops frequently in patients with obesity or overweight. 9, 10 Conventional BP measurements remain the fundamental technique of BP recording, but ABPM is widely used especially in clinical practice permitting, among other things, the calculation of BP load. SBP load over 50% and DBP load over 40% indicate an increased risk of organ complications in the course of arterial hypertension. This prognostically adverse phenomenon was observed in both groups of the present study. The increased risk phenomenon was observed in both groups of the present study. The increased risk of organ complications is also associated with a less than 10% nocturnal fall in BP. [11] [12] [13] In our groups the nocturnal BP fall was similar, ie, about 9% for systolic and about 13% for diastolic BP. When analysing these results one should take into consideration the fact that in both groups hypertension was not well controlled. Our primary objective was to find out whether both groups are comparable with respect to BP parameters, therefore for the purposes of this study it was sufficient to standardise pharmacotherapy. The lack of significant inter-group differences in BP may be accounted for by a similar duration and severity of hypertension.
Silent myocardial ischaemia indicates ischaemia of the myocardium without associated anginal pain or its equivalents.
14 Although SMI does not cause pain, it is associated with adverse clinical course. This has been confirmed both in patients with myocardial infarction and in patients with stable or unstable angina pectoris. [15] [16] [17] Our patients, in whom continuous ECG recording revealed SMI, were asymptomatic, ie, they belonged to a group with SMI type 1 in Cohn's classification.
14 A higher proportion of SMI patients with NIDDM, longer duration and larger number of ST segment depressions indicate more severe ischaemia in this group of patients. This is in accordance with other investigators reporting at least a twice as high risk of CAD in hypertensives with diabetes mellitus than in hypertensives without diabetes. 18, 19 Numerous epidemiological studies indicate that cardiac episodes and also SMI have a circadian pattern. [20] [21] [22] [23] [24] [25] Asmar et al 26 analysed ST segment depressions in continuous ECG monitoring in asymptomatic patients with mild and moderate essential arterial hypertension. The distribution of SMI episodes in these patients had revealed two peaks.
The present study also reveals the circadian pattern of SMI episodes. The highest number of episodes was noted in the morning between 05.00 and 09.00, and in the evening between 17.00 and 21.00. These numbers correspond to the above data.
In the present study LVH was found in about 75% of patients in group I and in 60% of patients in group II. A slightly higher, although nonsignificant, proportion of patients with LVH in group I most probably results from overweight accompanying NIDDM. The Framingham study demonstrates that overweight strongly correlated with the presence of LVH. It has been established that at each level of arterial BP the development of LVH increases markedly with increasing BMI. 27 Substantial evidence indicates that LVH predisposes to ischaemic heart disease due to increased myocardial oxygen demand and decreased coronary reserve. It may therefore be hypothesised that the increased BMI and the slightly higher proportion of LVH patients among diabetics increase the number of patients with SMI in the diabetic group.
In both groups total cholesterol, LDL cholesterol and triglycerides (TG) exceeded the normal range, and HDL cholesterol was decreased, thus indicating mild to moderate risk of coronary artery disease. It is noteworthy that the level of TG was relatively high in group I (3.14 mmol/I).
Conclusion
The present study carried out in hypertensives with and without diabetes mellitus with similar BP values and profile and without significant differences in the incidence and severity of LVH, indicates that the incidence of silent myocardial ischaemia and its severity were higher in hypertensives with than those without diabetes mellitus. In a group of patients with multiple coronary risk factors but without anginal pain, screening for silent myocardial ischaemia may be useful in identifying those at highest risk.
